Business EconomyPosted at: Nov 5 2025 12:02AM


Bharat Biotech's Nucelion sets up CRDMO to focus on next generation cell & gene therapy

Hyderabad, Nov 4 (UNI) Nucelion Therapeutics Pvt Ltd, a wholly owned subsidiary of Bharat Biotech International Ltd, established a Contract Research Development and Manufacturing Organisation (CRDMO) focused on cell and gene therapies in Hyderabad.
The CRDMO aims to support global life science innovators with high-quality, scalable process development and manufacturing solutions for advanced therapies, indicated for cancers, autoimmune disorders, and rare genetic disorders, the vaccine maker said in a release here today.
Setting up of the wholly-owned subsidiary Nucelion Therapeutics is the part of Bharat Biotech's strategic expansion into the fast-growing field of next-generation Cell and Gene Therapy Contract Research Development and Manufacturing Organisation (CRDMO).
Spread across a 30,000 square foot purpose-built facility in Genome Valley, Nucelion has commissioned a GMP facility capable of developing and manufacturing plasmids, viral and non-viral vectors, cell therapies, and aseptic fill & finish, providing end-to-end services for clients.
The company will offer end-to-end services, from early-stage clinical development to commercial-scale manufacturing, while adhering to international regulatory standards, including those of the FDA and EMA.
Dr. Krishna Ella, Non-Executive Director, Nucelion Therapeutics, said, "The future of pharmaceutical innovation will be biological; CGTs are a key vector. Our vision is to integrate advanced therapy platforms into India's healthcare ecosystem, enabling equitable solutions for complex and rare diseases."
Dr. Raghu Malapaka, Chief Business Officer, Nucelion Therapeutics, said, " Nucelion offers services for the development and manufacturing of plasmid DNA, Viral Vectors, Autologous, and Allogeneic Cell Therapies.
UNI KNR SS
Please log in to get detailed story.
Tags: #Bharat Biotech's Nucelion sets up CRDMO to focus on next generation cell & gene therapy
More News

Credit card spend increased 23 pc in September to Rs 2 17 lakh crore

08 Nov 2025 | 1:04 AM

Chennai, Nov 7 (UNI) The swiping of credit cards for spending increased by 23 percent in September 2025 year-on-year (y-o-y) and by 13 percent sequentially to Rs 2.17 lakh crore, said credit rating agency CARE Ratings.

see more..

Partners Group completes acquisition of Infinity Fincorp

08 Nov 2025 | 12:26 AM

Chennai, Nov 7 (UNI) Non-banking finance company (NBFC) Infinity Fincorp Solutions, focused on India’s micro, small, and medium enterprises (MSME) sector, on Friday announced the completion of its acquisition by Partners Group, one of the largest firms in the global private markets industry, acting on behalf of its clients as a majority investor.

see more..

'Each country entitled to its right share of tax' says official while urging for appropriate policies

07 Nov 2025 | 8:39 PM

New Delhi, Nov 7 (UNI) Raman chopra, principal chief commissioner of Income Tax, said on Friday that each country is entitled to its right share of tax in respect of every international transaction.

see more..

Kottayam-Kochi Rubber Market Rates

07 Nov 2025 | 7:31 PM

Kottayam Nov 7 (UNI) Following were the Rubber Market rates announced by the Rubber
Board here today per quintal.

see more..

Telangana Minister Sridhar Babu invites Utah entrepreneurs to invest in emerging sectors

07 Nov 2025 | 7:22 PM

Hyderabad, Nov 7 (UNI) IT and Industries Minister Duddilla Sridhar Babu on Friday urged entrepreneurs from the U.S. state of Utah to explore investment opportunities in Telangana, highlighting the state’s robust industrial ecosystem and investor-friendly reforms.

see more..